CNSYNASDAQ·USD·Closed·Healthcare · Medical - Pharmaceuticals

Cerenome, Inc.

$1.57−$0.07 · −4.27%day vs prior

Mkt Cap · USD

11.92M

P/E · TTM

-0.0

Div Yield · ann

–

52-week

$1.49 – $19.00

at 0% of range

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.

Loading chart data...

Signal state